PSMA uptake (SUV(bw)max) and DWI MRI (ADCmax and ADCmin) were found to be distinct biomarkers able to differentiate between clinically significant PCa and normal prostatic tissue in naïve prostate cancer patients with a Gleason Score ≥7 [34,35]. The gene discussed is FOLH1; the disease is prostate cancer.